期刊文献+

IGFBP-3、bFGF、Ki-67蛋白在非小细胞肺癌组织中的表达及意义 被引量:6

Expression and significance of IGFBP-3,bFGF and Ki-67 in non-small cell lung cancer
原文传递
导出
摘要 目的研究胰岛素样生长因子3(IGFBP-3)、碱性成纤维细胞生长因子(bFGF)、核增殖抗原(Ki-67)蛋白在非小细胞肺癌(NSCLC)中的表达及意义。方法应用免疫组化技术对60例NSCLC组织中IGFBP-3、bFGF、Ki-67抗原表达进行检测和分析。结果IGFBP-3、bFGF和Ki-67抗原表达率分别为71.67%(43/60)、56.67%(34/60)和68.33%(41/60);IGFBP-3和Ki-67表达与肿瘤分化程度、分期及淋巴结转移有关(P<0.05);bFGF表达与淋巴结转移及分期有关(P<0.05),与肿瘤的分化程度无关;三种标记的阳性表达与年龄、性别、组织类型无显著相关性(P>0.05)。IGFBP-3和bFGF、Ki-67的表达呈负相关(P<0.05)。结论在NSCLC组织中检测IGFBP-3、bFGF、Ki-67的表达对于判断NSCLC患者预后具有重要意义。 Objective To investigate the expression and significance of insulin-like growth factor-binding protein-3 (IGFBP-3), bFGF and Ki-67 in human non-small cell lung cancer (NSCLC). Methods The expressions of IGFBP-3, bFGF and Ki-67 were detected and analyzed in 60 cases with NSCLC by immunohistological technology. Results The positive rates of IGFBP-3, bFGF and Ki-67 were 71.67% (43/60), 56. 67% (34/60) and 68.33% (41/60), respectively. The positive rates of IGFBP-3 and Ki-67 were correlated with clinical stages, tumor differentiation and the lymph nodes metastasis (P〈0. 05). The positive rate of bFGF was significantly higher in the cases with local nodal metastasis and higher clinical stages. The expression of IGFBP-3 was negatively correlated with that of bFGF and Ki-67 in NSCLC. Conclusion Detecting the expressions of IGFBP-3, bFGF and Ki-67It is of importence in predicting the prognosis of patients with NSCLC.
出处 《江苏医药》 CAS CSCD 北大核心 2009年第1期41-43,I0004,共4页 Jiangsu Medical Journal
关键词 IGFBP-3 BFGF KI-67 非小细胞肺癌 IGFBP-3 bFGF Ki-67 Non-small cell lung cancer
  • 相关文献

参考文献10

二级参考文献10

  • 1Oyama T,J Immunol,1998年,160卷,1224页
  • 2Gabrilovich D I,Nature Med,1996年,2卷,1096页
  • 3Elston CW, Ellis IO. Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology,1999,19:403-410.
  • 4Susan H, Lee MD, Maureen A, et al. The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression and hormone receptor status in breast cancer. Am J Surg, 2003,186: 348-350.
  • 5Faneyte IF,Schrama JG,Peterse JL, et al. Breast cancer response to neoadjuvant chemotherapy., predictive markers and relation with outcome. British journal of Cancer, 2003,88 : 406-412.
  • 6Petit T, Borel C, Ghnassia JP, et al. Chemotherapy response of breast cancer depends on C-erbB-2 status and anthreacycline dose intensity in the neoadjuvant setting. Clinical Cancer Research,2001,7: 1577-1581.
  • 7Geisler S, Lonning PE, Aas T, et al. Influence of p53 gene alterations and c-erbB-2 expression on the response on the response to treatment with doxorubicin in locally advance breast cancer.Cancer Res, 2001,61 : 2505-2512.
  • 8Mai Nguyen. Angiogenic factors as tumor markers[J] 1997,Investigational New Drugs(1):29~37
  • 9江晓丰,董强刚,冯久贤,包国良,沙慧芳,王恩忠.非小细胞肺癌的血管生成和血管生成因子表达[J].肿瘤,1999,19(1):24-26. 被引量:8
  • 10许昱.Ki67及其在中耳胆脂瘤研究中的应用[J].国外医学(耳鼻咽喉科学分册),1999,23(3):146-150. 被引量:15

共引文献64

同被引文献76

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部